¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1649523
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,715,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,583,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº CAGR 2.62%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2025³â 11¾ï 7,400¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 13¾ï 3,600¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº Ç׸»¶ó¸®¾ÆÁ¦ÀÌ¸ç ¸»¶ó¸®¾Æ³ª ·ù¸¶Æ¼½º °üÀý¿°, ·çǪ½º µî ÀÚ°¡¸é¿ªÁúȯÀÇ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº ¿°ÁõÀ» ¾ïÁ¦ÇÏ°í ¸é¿ª°è¸¦ Á¶ÀýÇÔÀ¸·Î½á ÀÚ°¡¸é¿ª ÁúȯÀÇ À翬À» ¾ïÁ¦ÇÏ°í ¸»¶ó¸®¾Æ ±â»ýÃæÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÇÏÀ̵å·Ï½ÃŬ·Î·ÎŲÀº ¾çÈ£ÇÑ ºÎÀÛ¿ë ÇÁ·ÎÆÄÀÏÀ» º¸À¯ÇÏÁö¸¸, ¶§¶§·Î À§ÀåÀÇ ¿°Áõ ¹× ÇǺΠ¹ßÁøÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¸ç, ¸¸¼ºÀûÀÎ »ç¿ëÀº ¸Á¸· Àå¾Ö¸¦ À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº COVID-19ÀÇ ´ëÀ¯Çà ½Ã Å« °ü½ÉÀ» ²ø¾úÁö¸¸, ±× È¿´ÉÀº Á¦ÇÑµÈ ÀÓ»ó½ÃÇè¿¡¼­¸¸ È®ÀεǾú½À´Ï´Ù. ´Ù¾çÇÑ ¸¸¼º ÁúȯÀ» °ü¸®Çϱâ À§ÇÑ ±ÍÁßÇÑ ¼±ÅÃÀÌ µÇ´Â °Í¿¡´Â º¯ÇÔÀÌ ¾øÀ¸¸ç, Àå±â°£ »ç¿ë°ú °ü·ÃµÈ ºÎÀÛ¿ëÀÇ °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ½ÅÁßÇÑ ¸ð´ÏÅ͸µÀÌ ÇʼöÀûÀÔ´Ï´Ù.

¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¸»¶ó¸®¾Æ´Â ¿©ÀüÈ÷ ¼¼°èÀûÀ¸·Î °¡Àå È®»êµÈ Áúº´ Áß ÇϳªÀ̸ç ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀ¸·Î È¿°úÀûÀ¸·Î Ä¡·áµË´Ï´Ù. World Malaria Report 2024¿¡ µû¸£¸é 2023³â ¼¼°è ¸»¶ó¸®¾Æ ȯÀÚ ¼ö´Â 2¾ï 6,300¸¸ ¸íÀ¸·Î Àü³âº¸´Ù Áõ°¡Çß½À´Ï´Ù. °°Àº ÇØ »ç¸ÁÀÚ ¼ö´Â ¾à 59¸¸ 7,000¸íÀ̾ú½À´Ï´Ù.

Áö¸®Àû ÀλçÀÌÆ®

¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº 5°³ Áö¿ªÀ¸·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì, ³²¹Ì, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÔ´Ï´Ù.

Á¾ÇÕÇϸé, ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº ¸¸¼º Áúȯ°ú ¸»¶ó¸®¾ÆÀÇ ÀÌȯÀ²ÀÇ »ó½Â¿¡ ´õÇØ, ´Ù¾çÇÑ Áö¿ª¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶³ª Áøº¸¿¡ ÀÇÇØ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦7Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : Áö¿ªº°

Á¦8Àå °æÀï ȯ°æ ¹× ºÐ¼®

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global hydroxychloroquine drugs market is projected to grow at a CAGR of 2.62%, from US$1.174 billion in 2025 to US$1.336 billion in 2030.

Hydroxychloroquine is an antimalarial medication commonly used to treat malaria, as well as autoimmune diseases such as rheumatoid arthritis and lupus. It works by inhibiting inflammation and regulating the immune system, which helps reduce flare-ups of autoimmune disorders and suppresses the growth of the malaria parasite. Overall, hydroxychloroquine has a favorable side effect profile; however, it can occasionally cause gastrointestinal irritation and skin rashes, with chronic use potentially leading to retinal damage. The drug gained significant attention during the COVID-19 pandemic, although its effectiveness for this purpose has only been supported by a few limited clinical trials. While it remains a valuable option for managing various chronic conditions, careful monitoring is essential due to possible adverse effects associated with long-term use.

Drivers of the Global Hydroxychloroquine Market:

Malaria remains one of the most widespread diseases globally, treated effectively with hydroxychloroquine. According to the World Malaria Report 2024, there were an estimated 263 million cases of malaria worldwide in 2023, marking an increase from previous years. In that same year, approximately 597,000 deaths were attributed to malaria.

Geographical Insights:

The global hydroxychloroquine market is segmented into five regions: North America, South America, Europe, the Middle East & Africa, and Asia-Pacific.

In summary, the global hydroxychloroquine market is expected to grow due to rising rates of chronic diseases and malaria, alongside increased awareness and advancements in healthcare infrastructure across various regions.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

The global Hydroxychloroquine drugs market is segmented and analyzed as follows:

By Application

By End-User

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY APPLICATION

6. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY END-USER

7. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY GEOGRAPHY

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

9. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â